Bevacizumab: Solution for I.V. infusion 100 mg in 4 mL, Solution for I.V. infusion 400 mg in 16 mL; Mvasi® Page last updated: 5 March 2021 Public Summary Document (PSD) November 2020 PBAC Meeting - (PDF 933KB) Public Summary Document (PSD) November 2020 PBAC Meeting - (Word 55KB)